510(k) device
Dexcom Smart Basal
Dexcom, Inc. · Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX, Class II) · First FDA decision Nov 18, 2025, newest Nov 18, 2025Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
13
Naming "Smart Basal"
MAUDE reports
0
Brand "Smart Basal", since 2015
PubMed studies
1
Mentioning "Smart Basal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dexcom Smart Basal
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Dexcom Smart Basal510(k)
K252818 · Decided Nov 18, 2025 · 75 days after receipt
Device type: Continuous Glucose Monitor Informed Insulin Dose Calculator (QRX) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38662CGS Administrators, LLCUpdated Sep 29, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38623Wellpoint FederalUpdated Jul 14, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38686WPS Insurance CorporationUpdated Jun 18, 2026
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38657Noridian Healthcare Solutions, LLCUpdated Oct 14, 2025
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38743Palmetto GBAUpdated Jul 19, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38664First Coast Service Options, Inc.Updated Jun 21, 2024
- Implantable Continuous Glucose Monitors (I-CGM)Local determinationIn effectL38617Novitas Solutions, Inc.Updated Jun 21, 2024
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Smart Basal", any status and sponsor, newest update first.
- DIA:CONN P8(Smart Insulin Pen) Study in Diabetes PatientsPivotal-lookingCompleted
G2e Co., LtdNot on our public-company list
NCT06406439 · 120 participants · Start May 21, 2024 · Primary completion Apr 2, 2025
Device: Smart Insulin Pen; Injection of bolus insulin via conventional therapy using insulin pen · For: Diabetes (Insulin-requiring, Type 1 or Type 2); Pancreatogenic Diabetes Mellitus
Sites: Gwangmyeong, South Korea; Seoul, South Korea; Goyang-si, South Korea · 9 sites in all
University of VirginiaAcademic, hospital or other
NCT06111508 · 30 participants · Start Nov 29, 2023 · Primary completion Sep 13, 2024
Device: Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs · For: Type 2 Diabetes
Sites: New York, New York; Charlottesville, Virginia
Eli Lilly and CompanyNot on our public-company list
NCT05893797 · 36 participants · Start Oct 5, 2023 · Primary completion Sep 16, 2024
Device: Tempo Smart Button; Dexcom G6 CGM and 1 more · For: Type 1 Diabetes; Type 2 Diabetes; Type 2 Diabetes Treated With Insulin
Sites: Strasbourg, France; Caen, France; Besançon, France · 9 sites in all
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Smart Basal", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QRX
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Smart Basal"[tiab]. The summary above synthesizes these.
- Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes.
Oser SM, Crystal C, Hames KC, et al. · Diabetes Ther · 2026
Other devices of this type
Also filed under product code QRX.
- SmartBolus CalculatorInsulet Corporation · 510(k) 2023
- MODI SystemDreaMed Diabetes, Ltd. · 510(k) 2026
- BlueStar CGM insulin dose calculatorWelldoc, Inc. · 510(k) 2023
- Omnipod 5 SmartBolus CalculatorInsulet Corporation · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.